Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

CCL3 (MIP-1a) plasma levels and the risk for disease progression in chronic lymphocytic leukemia.

CCL3 (MIP-1a) plasma levels and the risk for disease progression in chronic lymphocytic leukemia. Blood. 2011 Feb 03; 117(5):1662-9.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.